U.S. Online Retail and Ecommerce Stock News

Clover Health Investments (NasdaqGS:CLOV) secured a court ruling requiring the Centers for Medicare & Medicaid Services to recalculate its 2026 Medicare Star Rating. The US District Court decision results in an upgrade for Clover Health's main PPO plan from 3.5 to 4.5 stars. The higher rating is expected to increase future CMS bonus payments tied to that plan's performance. The ruling reverses a prior downgrade and strengthens Clover Health's position within the Medicare Advantage...

Seagate Technology Holdings (NasdaqGS:STX) has secured near-full allocation of its nearline hard drive capacity through calendar 2027. The long term commitments are backed by multi year purchase agreements with key customers. Management has raised its annual revenue growth target to at least 20% based on this contracted demand. For investors watching Seagate at a share price of $868.09, this capacity lock in comes after a period of very strong stock performance, including a return of 201.9%...

If you are wondering whether Hecla Mining's current share price offers value or is running ahead of itself, the next sections break down what the numbers actually say about the stock. The share price closed at US$14.99, with the stock down 10.9% over the past week and 27.1% over the past month, although the 1-year return of 150.5% and 3-year return of 190.3% still stand out. These swings in performance have kept Hecla Mining on many investors' watchlists, as the stock has moved sharply both...

Wondering whether AMN Healthcare Services at around US$30.79 is offering value right now or just catching your eye after a big move. The stock is up 0.6% over the last week and 4.5% over the past month, with a 103.6% return year to date and a 42.4% gain over the last year, even though the share price has fallen 71.6% over three years and 67.7% over five years. Recent coverage has focused on how AMN Healthcare Services fits into investor interest around healthcare staffing and workforce...

This article examines whether Equinix, at around US$1,043 per share, is offering good value or embedding high future expectations, by breaking down what the current price might be implying. Over the past week the stock is down 4.2% and over the past month it is down 3.5%. Year to date it is up 36.5% and over the last year it has returned 19.0%, which naturally raises questions about how much of that performance is already reflected in the price. Over the last three and five years, Equinix...

Etsy (NYSE:ETSY) and its subsidiary Depop have released a joint whitepaper calling for regulatory reforms to support the circular economy and secondhand market. The paper urges policymakers to update rules, reduce administrative and tax frictions, and provide more support for microbusinesses selling pre owned goods. This move highlights Etsy's effort to influence policy around resale activity and align its marketplace with emerging circular economy priorities. Etsy runs a global marketplace...

Nutanix (NasdaqGS:NTNX) has partnered with San José Mineta International Airport to open The Nest by Nutanix, a sensory-friendly room for children with autism and sensory sensitivities. The dedicated space is now available to traveling families at SJC, offering a calmer environment before boarding. This initiative adds a community focused dimension to Nutanix’s profile, which is typically centered on its software and cloud offerings. Nutanix, trading at around $49.21 per share, has seen...

Astera Labs (NasdaqGS:ALAB) is scheduled to be added to the Nasdaq-100 Index in June 2026. This index inclusion marks a key milestone in the company’s public life and recognition within the AI infrastructure sector. The move may affect how global investors and index-tracking funds gain exposure to the stock. For investors tracking AI hardware, Astera Labs now sits alongside some of the largest US-listed companies through its upcoming addition to the Nasdaq-100 Index. The stock trades at...

CBRE Group (NYSE:CBRE) has promoted Jeremy Chism to managing director and market leader for Memphis and Jackson, Mississippi. The appointment places an experienced executive over key Southeast markets, with responsibilities across multiple property types. The move comes as CBRE is recognized for strong financial and operational performance and a solid outlook for growth. For you as an investor, this promotion speaks directly to how CBRE Group, a global commercial real estate services...

Virgin Galactic Holdings (NYSE:SPCE) has converted a portion of its debt into equity, which reduces future cash interest payments and extends debt maturities. The company has resolved governance related claims through a settlement that includes corporate reforms. These steps come as Virgin Galactic targets key flight tests in Q3 and the start of commercial operations in Q4 2026. For investors watching NYSE:SPCE, these balance sheet and governance changes arrive after a sharp move in the...

If you are wondering whether Texas Instruments' current share price still offers value, it helps to step back and look at what the recent returns and valuation checks are really telling you. The stock closed at US$297.10, with the share price down 2.7% over the last 7 days, slightly up 0.7% over the last month, and showing returns of 67.4% year to date and 53.0% over the past year. Recent coverage has focused on the stock's multi year share price performance, with returns of 82.1% over 3...

OUTFRONT Media Inc. recently completed a US$500.0 million private offering of 6.000% senior notes due 2034 and filed a US$105.44 million shelf registration for 3,373,000 common shares tied to an ESOP-related offering, both aimed at past balance sheet management and funding flexibility. Together, the refinancing of its 5.000% senior notes due 2027 and the new equity shelf expand OUTFRONT Media’s financial options to support its ongoing digital billboard and transit investments. We’ll now...

Outlook Therapeutics (OTLK) has moved back into focus after resubmitting its Biologics License Application to the FDA for ONS-5010/LYTENAVA for wet age related macular degeneration, following a successful appeal of a prior Complete Response Letter. See our latest analysis for Outlook Therapeutics. Investors appear to be reacting to the BLA resubmission and upcoming FDA decision. The latest share price is US$1.10, with a 30 day share price return of 353.61%. However, the 1 year total...

Recently, analysts raised their earnings estimates for ReNew Energy Global, with the stock now carrying a stronger Zacks Rank that reflects improving earnings expectations. This shift in analyst sentiment highlights how perceived earnings momentum can influence investor confidence in a renewable power producer like ReNew. Next, we’ll examine how these upward earnings estimate revisions may influence ReNew Energy Global’s broader investment narrative and risk-reward profile. The future of...

Fabrinet stock snapshot Fabrinet (FN) has been drawing attention after a sharp weekly pullback, with the stock down about 18% over the past week and about 8% over the past month, despite strong multi year total returns. See our latest analysis for Fabrinet. Despite the recent slide, Fabrinet’s share price is still up 21.45% year to date, and the 1-year total shareholder return of 126.58% underlines how strong the longer-term performance has been. If this kind of sharp pullback after a strong...

For investors wondering whether Manhattan Associates at US$140.29 is starting to look appealing or still feels expensive, this article focuses squarely on what the current price might imply about value. The stock has been volatile recently, with a share price that rose about 4.0% over the last month but is still down about 16.1% year to date and about 27.3% over the past year. Recent headlines have focused on how supply chain software providers are being reassessed by investors as...

NIQ Global Intelligence stock snapshot NIQ Global Intelligence (NIQ) has been on many investors’ radar after recent trading showed the stock down about 2% over the past day, 3% over the past week, and 21% over the past month. See our latest analysis for NIQ Global Intelligence. At a share price of $8.16 and with the year to date share price return down 48.29%, momentum has clearly been fading. This suggests recent moves reflect shifting expectations around NIQ’s growth potential and risk...

Morgan Stanley’s June 10 downgrade of Hess Midstream (HESM) to Underweight, citing high valuation, limited growth visibility, and sponsor strategy uncertainty, has put fresh focus on how much of the stock’s story is already priced in. See our latest analysis for Hess Midstream. Hess Midstream’s share price has eased slightly in recent weeks, with the stock down over the past month and quarter, even though the year to date share price return is positive and longer term total shareholder...

If you are wondering whether Aon at around US$335 per share looks expensive, cheap, or somewhere in between, the starting point is understanding what the current price actually reflects. Over the past week the stock is up 4.0%. Over the past month it is up 5.9%. Year to date the share price is down 2.6% and over the last year it has declined 4.9%. This mix of recent gains and longer term declines can leave you questioning whether recent strength is the start of a recovery or just a short...

SailPoint, Inc. has already reported fiscal first-quarter 2026 results, with revenue rising to US$280.14 million from US$230.47 million a year earlier and net loss narrowing to US$74.67 million, or US$0.13 per share, from US$187.31 million, or US$0.42 per share. Management highlighted strong demand for its identity security platform, particularly in cloud and AI-related use cases, while investors weighed this progress against ongoing losses, cautious guidance, and increased insider share...

Devon Energy (NYSE:DVN) has released its first full operational and capital return outlook after closing its merger with Coterra Energy. The company outlined production goals, a plan to return up to 70% of free cash flow to shareholders, and targeted cost synergies for the combined business. Management also highlighted a sharper focus on the Permian Basin as a core growth and efficiency hub for the merged portfolio. For you as an investor, this is the first clear look at how the merged...

Celldex Therapeutics (NasdaqCM:CLDX) plans to present new clinical results for barzolvolimab in chronic and cold urticaria at the 2026 European Academy of Allergy and Clinical Immunology Congress. The company will also share first in human Phase 1 data for CDX-622, targeting KIT signaling in mast cells. These data represent fresh updates on Celldex’s core pipeline that have not been covered in earlier reports. Celldex enters this data update with its stock at $29.96 and a return of 47.2%...

Personalis, trading on NasdaqGM:PSNL, has received Class A CE-IVD marking for its EDTA and cfDNA Blood Collection Kits under the EU In Vitro Diagnostic Regulation. The certification enables the kits to be used in clinical trials across the EU and Great Britain for its ultrasensitive minimal residual disease, or MRD, testing. This regulatory step supports wider international adoption of Personalis' oncology testing platform in large, multi country studies. For investors tracking...

Intuit (NasdaqGS:INTU) plans to lay off 17% of its global workforce as part of a broad effort to streamline operations. The company is reallocating resources to focus more heavily on artificial intelligence projects and related products. This move reflects management’s response to pressure around AI driven disruption and questions about its AI monetization approach. For investors watching Intuit, the scale of this restructuring comes at a time when the stock has faced sharp pressure...